Scientists have identified distinctive patterns in blood antibodies that may help predict inflammatory bowel disease (IBD) up to 10 years before a person receives a diagnosis. The findings could eventually support earlier risk assessment and help researchers understand how these long-term digestive conditions develop.
It examined immune-system changes in people who later developed Crohn’s disease or ulcerative colitis, two major forms of IBD.
What the Researchers Discovered
The research team analysed 2,000 blood serum samples from 500 people. The group included 200 individuals who later developed Crohn’s disease, 200 who developed ulcerative colitis and 100 healthy comparison participants.
Samples had been collected at diagnosis and at earlier points, including approximately two, four and 10 years beforehand. Researchers examined antibody responses to around 357,000 targets associated with microbes, viruses, food and the immune system.
The analysis revealed different antibody patterns in people who later developed IBD. Some of these differences were detectable years before diagnosis, suggesting that immune-system changes can begin well before the condition is recognised clinically.
Different Patterns in Crohn’s Disease and Ulcerative Colitis
People who later developed Crohn’s disease showed increased antibody responses to certain viruses, including herpesviruses, as well as bacterial flagellin. Some patterns were particularly noticeable among those who later developed more complicated disease.
People who went on to develop ulcerative colitis showed a different combination of immune responses, including changes involving viruses and the body’s own proteins.
Researchers used machine-learning models to combine these antibody patterns. The models distinguished future Crohn’s disease cases from healthy controls with an area-under-the-curve score of 0.90, and ulcerative colitis cases with a score of 0.84. These are measures of how well a model separates groups in the research data, not guarantees that it can accurately predict an individual’s future health.
Why Early Detection Could Matter
IBD can cause long-term inflammation in the digestive tract and may affect a person’s quality of life. Identifying biological changes before symptoms emerge could eventually help doctors recognise people at higher risk and study whether earlier intervention might improve outcomes.
The findings may also help scientists investigate the processes that contribute to Crohn’s disease and ulcerative colitis, including interactions between the immune system and microorganisms.
The Research Is Not Yet a Routine Screening Test
The results are promising, but the antibody analysis remains a research approach rather than an established screening test. Scientists need to validate the findings in larger, more diverse populations and determine whether the method adds useful information beyond existing clinical and genetic assessments.
The study also does not prove that the identified antibody patterns cause IBD. Further research is needed before this approach can be used to guide routine medical decisions.
For now, the findings represent a step towards understanding how inflammatory bowel disease may develop years before diagnosis and whether future tests could help identify risk earlier.
